COMPASS Pathways plc SEC filings CMPS
COMPASS Pathways plc has 344 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 15, 2026 | May 27, 2026 |
| DEF 14A | Proxy statement | Apr 28, 2025 | Apr 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2025 | Apr 16, 2025 |
| DEF 14A | Proxy statement | Apr 8, 2024 | Apr 8, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2024 | Mar 28, 2024 |
| DEF 14A | Proxy statement | Apr 19, 2023 | Apr 19, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 16, 2022 |
Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CMPS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Chesire, United Kingdom
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1816590
- Former names
- Compass Rx Ltd. (until Aug 10, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.